comprehensive -WSS

comprehensive

author：focus 2025-08-25 16:34:07 - browse：9

Americans who suffer severe allergic reactions won’t have alternatives to auto-injectors like the EpiPen for a while longer. In a surprise move, the Food and Drug Administration on Tuesday declined to approve neffy, an epinephrine nasal spray. Instead, the FDA asked the drug’s manufacturer, ARS Pharma, to conduct further studies, specifically comparing the effect of repeat doses of epinephrine administered via nasal spray versus auto-injection in people with allergic rhinitis, or hay fever.

This was unexpected, and disappointing, for ARS Pharma: In May, an FDA advisory committee had voted 16-6 in favor of neffy’s approval for adults, and 17-5 in favor for children. But there is at least one party that’s likely to benefit from this development: Viatris, the maker of EpiPen, the brand-name epinephrine auto-injector used to treat anaphylaxis. (A generic version is also available, made by Teva).

In June, Viatris filed a citizen petition with the FDA, saying that the available evidence left doubts about how neffy would actually perform in a real-life anaphylactic event compared to auto-injectable epinephrine.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： RSV shot was 90% effective at preventing hospitalizations in kids

WSS

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

House passes resolution saying Israel isn't a 'racist or apartheid state'

First medicine developed to treat MASH expected to be approved soon

explore

comprehensive

leisure time

Cancer drug shortages should be causing more outrage

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Moonlake's readout produced a cash windfall. Risks remain

Lack of darker skin in textbooks, journals harms patients of color

Tori Bowie and the unacceptable rates of Black maternal death

BridgeBio heart drug succeeds in pivotal study

Tori Bowie and the unacceptable rates of Black maternal death

A look at other Americans who have crossed into North Korea over the years

Anesthesiologist group: stop taking Ozempic before surgery

US soldier in North Korean custody after crossing DMZ line

focus

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Manchin plays down potential 3rd

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Just how do doctors, lawmakers, and the public define abortion?

Robert Kennedy Jr.'s presidential campaign attracts GOP

How to bring more disabled researchers into academia

leisure time

focus

entertainment

explore